Sam Altman invested $180 million into a company trying to delay death
When a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million
Read MoreWhen a startup called Retro Biosciences eased out of stealth mode in mid-2022, it announced it had secured $180 million
Read MoreThis is today’s edition of The Download, our weekday newsletter that provides a daily dose of what’s going on in
Read More